Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AAIPharma | Contract Pharma
Breaking News, Promotions & Moves

AAIPharma

AAIPharma, Inc. has appointed Ninad Deshpanday, Ph.D. to the newly created position of vice president of pharmaceutical business development. Dr. Deshpanday will be responsible for all North American business development activities in Pharmaceutical Development, including Analytical, Biotechnology, Formulations Development, GMP Manufacturing and Clinical Trial Materials for both Oral and Parenteral dosage forms.

Dr. Deshpanday has more than 15 years’ experience in pharmaceutical development. Prior to joining the company, he was vice president of drug product development for Synta Pharmaceuticals, with responsibilities for all CM&C activities. Prior to that, he served as technical business director for the pharmaceutics division of Cardinal Health. Previously, Dr. Deshpanday held leadership positions at AAIPharma, including senior manager of formulations development and global product director of pharmaceutics.

“Dr. Deshpanday possesses a unique combination of leadership skills and technical expertise in pharmaceutical development, and is a great addition to our business development team,” stated Pete Megronigle, senior vice president of North American business development. “This appointment represents AAIPharma’s continued focus on maximizing technical capabilities with regional effectiveness and broadening its position in the marketplace.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters